Overview
- Bill Ackman and his wife Neri Oxman publicly announced the Ackman Oxman Institute and seeded it with roughly $400 million in Pershing Square stock, a transfer confirmed by an SEC filing.
- The institute has acquired a nearly vacant 400,000-square-foot West Side biotech facility and has an adjoining 130,000-square-foot building under contract, creating a campus that could expand to about 680,000 square feet under current zoning.
- AOI is structured as a patient‑centered nonprofit with a built‑in venture arm meant to seed and spin out companies so discoveries move from lab to treatments faster and returns can be reinvested in research.
- The project was driven by the Ackman family’s experience after their daughter suffered a catastrophic brain hemorrhage earlier this year, and AOI will prioritize rehabilitation, brain‑computer interfaces and AI to restore lost functions.
- AOI has named a board that includes leading scientists and inventors and is searching for senior executives, with a CEO expected by October; the model raises near‑term questions about governance, regulatory pathways for devices and the ethics of rapid commercial translation.